Application no. and date | 18788905.0 (espacenet) (Federated) (European Patent Register), 20180927 | Patent/reg. no. and date | DK/EP 3687513, 20211215 | Publication date | 20200805 | Priority no. and date | US 201762564834 P, 20170928, US 201862632532 P, 20180220 | EP pub. no. and date |
EP 3687513 20200805 | Effective date | | Applicant/owner | Harmony Biosciences Management, Inc., 630 W. Germantown Pike Suite 215
Plymouth Meeting, PA 19462, US | Applicant ref. no. | P79054DK01 | Inventor | BONN-MILLER, Marcel, 1112 Riverwood Road
Lexington, NC 27292, US, GUTTERMAN, Donna, 10409 Veasey Mill Road
Raleigh, NC 27615, US, MESSENHEIMER, John, 55 Hermitage Lane
Moncure, NC 27599, US, SEBREE, Terri, 922 Merion Square Road
Gladwyne, PA 19035, US, TICH, Nancy, 318 Summit Avenue
St. Paul, MN 55102, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/05 (2006.01) , A61P 25/00 (2006.01) | Title | BEHANDLING AF FRAGILT X-SYNDROM OG AUTISME MED CANNABIDIOL | Int. application no. | IB2018057519 | Int. publication no. | WO2019064234 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|